National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

glycosylated recombinant human G-CSF AVI-014
A glycosylated form of a recombinant agent that is chemically identical to or similar to endogenous human granulocyte colony-stimulating factor (G-CSF) and is produced using transgenic biotechnology. Transgenic hens carrying recombinant human G-CSF cDNA express the naturally glycosylated recombinant human protein in egg albumen from which glycosylated recombinant human G-CSF AVI-014 is isolated. Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:glycosylated rhG-CSF AVI014
Code name:AVI-014



Previous:glucosamine sulfate/chondroitin sulfate tablet, glutamine, glutathione disulfide NOV-002, glycine, glycopeptide antibiotic
Next:glycosylated recombinant human interleukin-7, GM-CSF-encoding oncolytic herpes simplex virus, GM-K562 cell vaccine, GM.CD40L cell vaccine, GM2-KLH vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov